These results were confirmed by Ma et al. [169], which demonstrated that this iridoid could reduce the hyperphosphorylation and aggregation of tau protein in the amygdala, prevent neuronal loss, and suppress the hyperactivity phenotype of AD. This evidence concerns the gene MAPT and Alzheimer disease.